Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects. [2006 Jan]

Complementary therapies for reducing body weight: a systematic review. [2005 Sep]

Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. [2004 Sep]

Comparison of the acute pharmacodynamic responses after single doses of ephedrine or sibutramine in healthy, overweight volunteers. [2004 Aug]

A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. [2004 Nov]

Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. [2002 Nov]

An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults. [2002 Oct]

An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. [2001 Mar]

The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans. [2000 Dec]

Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. [2000 Dec]

Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity. [1999 Jul]

[A randomized comparison of two weight-reducing diets. Calorie counting versus low-fat carbohydrate-rich ad libitum diet] [1998 Feb 02]

Is an ephedrine caffeine treatment contraindicated in hypertension? [1997 Aug]

Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake. [1997 Jan 04]

The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet. [1994 May]

Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. [1994 Feb]

The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans. [1993 Dec]

Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity. [1993 Feb]

Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. [1993 Feb]

The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. [1992 Apr]

Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects. [1992 Jan]

Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients. [1991 Aug]

Central nervous system biogenic amine targets for control of appetite and energy expenditure. [2006 Feb]

Pharmacotherapy for obesity. [2005]

Dietary supplements in weight reduction. [2005 May]

Adverse events of herbal food supplements for body weight reduction: systematic review. [2005 May]

Diabesity: are weight loss medications effective? [2005]

[Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies] [2004 Nov]

Severe maternal bradycardia and asystole after combined spinal-epidural labor analgesia in a morbidly obese parturient. [2004 Sep]

A perspective on the current strategies for the treatment of obesity. [2004 Oct]

[Case of circulatory depression in an obese patient in prone position during general anesthesia] [2004 Sep]

Rhabdomyolysis in response to weight-loss herbal medicine. [2004 Jun]

Treating obesity: pharmacology of energy expenditure. [2004 Apr]

Dietary supplements for body-weight reduction: a systematic review. [2004 Apr]

Supplemental products used for weight loss. [2004 Jan-Feb]

Acute myocardial infarction induced by ephedrine alkaloids. [2003 Dec]

Ischemic stroke after using over the counter products containing ephedra. [2004 Jan 15]

[Dietary supplements and functional food for weight reduction -- expectations and reality] [2003 Oct 16]

Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. [2002]

Ephedra in perspective--a current review. [2003 Aug]

Cocaine and ephedrine-induced priapism: case reports and investigation of potential adrenergic mechanisms. [2003 Jul]

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. [2003 Mar 26]

Treatment of obesity: an update on anti-obesity medications. [2003 Feb]

[Ephedrine and ephedra in weight loss products and other preparations] [2002 Jul 13]

The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. [2001 Aug]

Acute psychosis due to the interaction of legal compounds--ephedra alkaloids in 'vigueur fit' tablets, caffeine in 'red bull' and alcohol. [2001 Oct]

Use of nonprescription weight loss products: results from a multistate survey. [2001 Aug 22-29]

Neuropeptide Y in obese women during treatment with adrenergic modulation drugs. [2001 May-Jun]

Dietary fat intake, supplements, and weight loss. [2000 Dec]

Thermogenic drugs as a strategy for treatment of obesity. [2000 Oct]

Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. [2000 Oct]

A concise review on the therapeutics of obesity. [2000 Oct]

Drug treatment of obesity. [1999 Apr]

Pharmaceutical cost savings of treating obesity with weight loss medications. [1999 Nov]

Current concepts in the pharmacological management of obesity. [1999 Jun]

Sudden death after typhoid and Japanese encephalitis vaccination in a young male taking pseudoephedrine. [1999 Feb]

What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice. [1998]

Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. [1998 Jul]

Drug therapy for obesity in the elderly. [1997 Nov]

Present and future pharmacological approaches. [1997]

Medicating the obese patient. [1996 Dec]

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. [1996 Nov]

Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women. [1996 Feb]

Pharmacological and clinical studies of ephedrine and other thermogenic agonists. [1995 Nov]

Combined drug treatment of obesity. [1995 Nov]

Thermogenic, anti-obesity effects of bofu-tsusho-san in MSG-obese mice. [1995 Oct]

Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoprotein lipase activity in obese over-fed rats. [1993 Jun]

Effects of ephedrine and aminophylline on resting energy expenditure in obese adolescents. [1993 Feb]

Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis. [1993 Feb]

Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition? [1992 Nov]

The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. [1992 Jul]

Pharmacology of thermogenic drugs. [1992 Jan]

Increased metabolic rate in obese women after ingestion of potassium, magnesium- and phosphate-enriched orange juice or injection of ephedrine. [1991 Jun]

The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat. [1991 Jun]

Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. [1991 Mar]

Ephedrine-induced thermogenesis as an adjunct to cognitive restructuring and covert conditioning: a proposal for treatment of obese individuals. [1989 Oct]